| Date | Time | Source | Headline | Symbol | Company |
| 10/15/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals Announces Positive Interim Results in Phase 2a Dermatology Program with RXI-109 | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 10/12/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals to Present at Premier Scientific Plastic Surgery Meeting | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 10/07/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals to Present at 14th Annual BIO Investor Forum | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 10/05/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals Bolsters Protection for its Novel Self-Delivering RNAi Platform with Notice of Allowance from USPTO | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 09/29/2015 | 8:57AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 09/29/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals to Present at Dawson James Securities Growth Stock Conference | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 09/28/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals Granted Patent in China for Lead Clinical Candidate RXI-109 | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 09/18/2015 | 9:10AM | PR Newswire (US) | Biotechnology Equities under the Scanner -- Gilead Sciences, Aeterna Zentaris, RXi Pharma, BioCryst Pharma, and Kite Pharma | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 09/15/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals to Present at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment Conference | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 09/08/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Ocular Indications | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 08/31/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 08/12/2015 | 7:17AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 08/12/2015 | 7:04AM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 08/12/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals Reports Second Quarter 2015 Financial Results and Business Highlights | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 07/31/2015 | 9:30AM | PR Newswire (US) | Biotechnology Stocks on our Scanner -- Agenus, RXi Pharma, Nektar Therapeutics, Genetic Technologies, and Agios Pharma | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 07/29/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015 | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/23/2015 | 7:36AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/09/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Novel RNAi Platform | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/08/2015 | 4:27PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/05/2015 | 12:01PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/05/2015 | 10:38AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/04/2015 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/03/2015 | 8:05AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/03/2015 | 8:04AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/03/2015 | 8:04AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/03/2015 | 8:03AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/03/2015 | 8:01AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/03/2015 | 7:02AM | PR Newswire (US) | RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/02/2015 | 6:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |
| 06/02/2015 | 6:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RXII | Rxi Pharmaceuticals Corp. (MM) |